Effectiveness and safety of dabigatran in Latin American patients with atrial fibrillation: Two years follow up results from GLORIA-AF registry

BACKGROUND: Real-world data from different regions are needed to support the external validity of controlled trials and assess the impact of new oral anticoagulants (NOAC) in clinical practice. METHODS: “GLORIA-AF” is a large, ongoing, multicenter, global, prospective registry program in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubner, Sergio, Saraiva, José Francisco Kerr, Fragoso, Juan Carlos Nunez, Barón-Esquivias, Gonzalo, Teutsch, Christine, Gurusamy, Venkatesh Kumar, Marler, Sabrina, Huisman, Menno V., Lip, Gregory Y.H., Zeballos, Cecilia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644920/
https://www.ncbi.nlm.nih.gov/pubmed/33195793
http://dx.doi.org/10.1016/j.ijcha.2020.100666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644920/
https://www.ncbi.nlm.nih.gov/pubmed/33195793
http://dx.doi.org/10.1016/j.ijcha.2020.100666

Ejemplares similares